z-logo
open-access-imgOpen Access
Elderly patients with stage III NSCLC survive longer when chemotherapy is added to radiotherapy—fortune favours the bold
Author(s) -
Surein Arulananda,
Paul Mitchell
Publication year - 2018
Publication title -
translational lung cancer research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.474
H-Index - 41
eISSN - 2226-4477
pISSN - 2218-6751
DOI - 10.21037/tlcr.2018.08.12
Subject(s) - medicine , radiation therapy , stage (stratigraphy) , chemotherapy , oncology , lung cancer , disease , paleontology , biology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom